Fig. 2From: Seroprevalence and dynamics of anti-SARS-CoV-2 antibodies: a longitudinal study based on patients with underlying diseases in WuhanComparison of antibody titers of symptomatic patients and asymptomatic patients among 219 subjects with positive total antibodies at baseline and three consecutive serum samples. Longitudinal changes in IgG of underlying disease group and no underlying disease groupBack to article page